Cubist Pharma (CBST) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	233.69M
Short-term investments	453.29M
Accounts receivable, net	115.13M
Inventory	68.71M
Deferred tax assets, net
Prepaid expenses and other current assets	54.68M
Total current assets	972.37M
Property and equipment, net	182.53M
In-process research and development	237.4M
Goodwill	381.93M
Other intangible assets, net	1.32B
Long-term investments
Other assets	86.66M
Total assets	3.18B
Accounts payable	30.17M
Accrued liabilities	167.93M
Short-term deferred revenue	7.12M
Short-term contingent consideration
Total current liabilities	274.89M
Long-term deferred revenue	27.4M
Long-term deferred tax liabilities, net	363.77M
Long-term contingent consideration
Long-term debt, net	843.49M
Other long-term liabilities	30.33M
Total liabilities	1.64B
Commitments and contingencies (Notes C, F, K and L)	0
Preferred stock, non-cumulative; convertible, $.001 par value; authorized 5,000,000 shares; no shares issued and outstanding	0
Common stock, $.001 par value; authorized 150,000,000 shares; 60,960,010 and 59,344,957 shares issued and outstanding as of June 30, 2011 and December 31, 2010, respectively	76K
Additional paid-in capital	1.44B
Accumulated other comprehensive (loss) income	-1.77M
Accumulated deficit	102.29M
Total stockholders' equity
Total liabilities and stockholders' equity	3.18B

Entities mentioned with CBST

View All Entities